G-H-3 International Inc.
GHTI
Other OTC0.00
USD
- -
- -
G-H-3 International Inc.
GHTI
(Other OTC)
Recent
price
0.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- G-H-3 International Inc. develops and markets anti-aging health care products aimed at addressing factors causing aging and bodily deterioration. Its primary product line includes the G-H-3-Plus protocol, which encompasses a comprehensive combination of intravenous treatments, intramuscular injections, prescription medications, vitamins, and skin care products. Operating mainly within the pharmaceuticals and biotechnology sectors, the company serves a health-conscious customer base focused on longevity and wellness. Founded in 1998 and headquartered in Las Vegas, Nevada, G-H-3 International conducts its business activity primarily in the United States. Recent company developments include the introduction of new formulations and expanded service offerings geared toward enhancing anti-aging treatment protocols, reflecting a strategic focus on product innovation and comprehensive health solutions in the biopharmaceutical domain within the last two years. The company remains publicly traded under the ticker GHTI on the over-the-counter markets. G-H-3 International's core activities center on research-driven product manufacturing and marketing designed to address aging-related health concerns with solutions combining medical treatments and consumer health products to attract a broad range of wellness-focused consumers. These efforts align with a strategic emphasis on expanding its presence in the health technology and biopharmaceutical industry segments domestically.